Aller au contenu
Santé mentale et cognitionEssai randomisé4 min read

Pre-workout supplement raised energy expenditure and alertness but not lifting or sprint output

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Effects of acute ingestion of a pre-workout dietary supplement with and without p- synephrine on resting energy expenditure, cognitive function and exercise performance. · Journal of the International Society of Sports Nutrition · 2017 · Article original ↗

À retenir

In 25 healthy, recreationally active adults, a single dose of a caffeine-containing pre-workout supplement, with or without p-synephrine, improved readiness and cognitive scores and resting energy expenditure responses, but did not significantly change bench press, leg press or sprint performance. This was a one-dose crossover test in young, healthy people, so it says little about repeated use or other groups.

Study design

Essai randomisé

Reading basis

Published abstract

Reading focus

Comparator & uncertainty

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Pre-workout supplements are widely used, and p-synephrine is a common added ingredient, yet their short-term effects on thinking, energy use and performance are unclear. The authors tested a pre-workout supplement with and without p-synephrine against a placebo for readiness to perform, cognitive function, exercise performance and safety markers.

Population et méthode

Randomized, double-blind, counterbalanced crossover trial in 25 healthy, recreationally active men and women. Each participant took a maltodextrin placebo, a pre-workout supplement (PWS; including beta-alanine 3 g, creatine nitrate 2 g, arginine alpha-ketoglutarate 2 g, caffeine 284 mg and other ingredients), or the supplement plus Citrus aurantium extract providing 20 mg p-synephrine. Heart rate, blood pressure, resting energy expenditure, 12-lead ECG, perceived readiness, Stroop Color-Word cognitive test, bench and leg press (2 sets of 10 repetitions at 70% of 1RM and 1 set to failure), Wingate sprint and blood samples were collected before and/or after. Analysis used repeated-measures MANOVA and mean changes from baseline with 95% CI. The trial was retrospectively registered (NCT02952014).

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    No clinically significant differences between treatments in heart rate, blood pressure, ECG or general clinical blood panels.
  2. 2
    Both supplement conditions produced greater changes in resting energy expenditure, and participants reported more optimism about performance and more vigor and energy than with placebo.
  3. 3
    Cognitive scores improved more from baseline with both supplement versions than with placebo after 1 or 2 h, but the scores with added p-synephrine never exceeded placebo or the supplement alone at any time point.
  4. 4
    No statistically significant differences among treatments in total bench press volume, leg press volume or Wingate sprint performance.

Limites et incertitude

  1. 1
    Only 25 young, healthy, recreationally active people took part, so results may not apply to athletes, older adults or people with heart conditions.
  2. 2
    The test was after a single dose, so the abstract says nothing about repeated use or longer-term safety.
  3. 3
    Retrospective registration of the trial means that the planned outcomes were not publicly fixed in advance.
  4. 4
    The supplement is a multi-ingredient blend containing 284 mg caffeine, so the effects cannot be attributed to any single ingredient. This reading is based on the abstract only.

Mise en perspective

A one-off dose of this blend felt energizing and lifted some mental scores, but did not make people lift more or sprint faster in this test. Adding p-synephrine gave little extra. If you have a heart condition, high blood pressure or take medication, check with a clinician before using stimulant-containing supplements.

Vos données

If you use a pre-workout product, resting heart rate, blood pressure readings and sleep afterward are the personal measures worth noting. Compare days with and without the product under the same conditions, and avoid reading one workout as proof of a benefit.

Comprendre ce type de preuve

Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

The purpose of this study was to examine the effects of acute ingestion of a pre-workout dietary supplement (PWS) with and without p- synephrine (S) on perceptions of readiness to perform, cognitive function, exercise performance, and markers of safety.

Methods

In a randomized, double-blind, and counterbalanced manner; 25 healthy and recreationally active male and female participants ingested a flavored maltodextrin placebo (PLA), a PWS containing beta-alanine (3 g), creatine nitrate as a salt (2 g), arginine alpha-ketoglutarate (2 g), N-Acetyl-L-Tyrosine (300 mg), caffeine (284 mg), Mucuna pruiriens extract standardized for 15% L-Dopa (15 mg), Vitamin C as Ascorbic Acid (500 mg), niacin (60 mg), folate as folic acid (50 mg), and Vitamin B12 as Methylcobalamin (70 mg) with 2 g of maltodextrin and flavoring; or, the PWS with Citrus aurantium (PWS + S) extract standardized for 30% p -synephrine (20 mg). Participants had heart rate (HR), blood pressure, resting energy expenditure (REE), 12-lead electrocardiograms (ECG), perceptions about readiness to perform, cognitive function (Stroop Color-Word test), bench and leg press performance (2 sets of 10 repetitions at 70% of 1RM and 1 set to failure), and Wingate anaerobic capacity (WAC) sprint performance determined as well as donated blood samples prior to and/or following exercise/supplementation. Data were analyzed by MANOVA with repeated measures as well as mean changes from baseline with 95% confidence intervals (CI).

Results

No clinically significant differences were observed among treatments in HR, blood pressure, ECG, or general clinical blood panels. There was evidence that PWS and PWS + S ingestion promoted greater changes in REE responses. Participants reported higher perception of optimism about performance and vigor and energy with PWS and PWS + S ingestion and there was evidence that PWS and PWS + S improved changes in cognitive function scores from baseline to a greater degree than PLA after 1 or 2 h. However, the scores in the PWS + S treatment did not exceed PLA or PWS responses at any data point. No statistically significant differences were observed among treatments in total bench press lifting volume, leg press lifting volume or WAC sprint performance.

Conclusions

Within the confines of this study, ingestion of PWS and/or PWS + S prior to exercise appears to be well-tolerated when consumed by young, healthy individuals. The primary effects appear to be to increase REE responses and improve perceptions about readiness to perform and cognitive function with limited to no effects on muscular endurance and WAC. The addition of 20 mg of p -synephrine to the PWS provided limited to no additive benefits.

Trial registration

This trial (NCT02952014) was retrospectively registered on September 13th 2016.

Sources et attribution

Effects of acute ingestion of a pre-workout dietary supplement with and without p- synephrine on resting energy expenditure, cognitive function and exercise performance.

Jung YP, Earnest CP, Koozehchian M, Galvan E, Dalton R, Walker D, Rasmussen C, Murano PS, Greenwood M, Kreider RB.

Journal of the International Society of Sports Nutrition · 2017-01-12

DOI: 10.1186/s12970-016-0159-2 ↗PubMed · 28096758 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Synthèse de revues

Exercise gave small-to-moderate cognitive gains across 133 reviews of trials

An umbrella review of 133 systematic reviews (2724 trials, 258,279 participants) found that exercise improved general cognition (SMD 0.42, 95% CI 0.37 to 0.47), memory (0.26) and executive function (0.24), with the largest memory gains in children and adolescents and the largest executive function gains in people with ADHD. Most of the reviews (94) were rated critically low in quality and the effects were smaller in the best-rated ones (0.23 for general cognition), and the outcomes were test scores, not dementia.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
·Méta-analyse observationnelle

More daily steps linked to fewer depressive symptoms across 33 studies of adults

Pooling 33 observational studies of 96,173 adults, higher daily step counts went with fewer depressive symptoms, and in the two prospective cohorts that could be pooled, 7000 or more steps a day went with a lower risk of depression than fewer (RR 0.69, 95% CI 0.62-0.77). Most studies were cross-sectional, so low mood may be reducing steps as much as steps affect mood, and the authors say the prediction intervals call for caution.

JAMA Network Open

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Exercise eased depression in 218 trials, but confidence in the evidence is low

In a network meta-analysis of 218 trials with 14,170 people who met criteria for major depression, walking or jogging, yoga, strength training, mixed aerobic exercise and tai chi or qigong each gave moderate reductions in depression compared with active controls (walking or jogging: Hedges' g −0.62, 95% credible interval −0.80 to −0.45). Confidence in the evidence was low for walking or jogging and very low for the other treatments, mainly because only one study met the low-risk-of-bias criteria.

BMJ

Explications approfondiesLire l’étude →
·Synthèse de revues

Physical activity eased depression and anxiety across 97 reviews of trials

Across 97 systematic reviews that pooled 1039 randomized trials with 128,119 participants, physical activity had medium effects on depression (median effect size −0.43) and anxiety (−0.42) compared with usual care, and higher-intensity activity went with larger gains. Most of those reviews (77) were rated critically low in quality, and the evidence mainly concerns mild-to-moderate symptoms.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
Santé mentale et cognition →